NCT00655174View on ClinicalTrials.gov

Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

September 30, 2006

Study Completion Date

January 31, 2007

Conditions
Autism
Interventions
DRUG

fluvoxamine

Children will be started on 12.5 mg. If there is no therapeutic effectivenss observed after eight weeks, then the child may have their dose increased. In this case, the child will be followed for an additional eight weeks.

DRUG

sertraline

Children will be started on 12.5 mg. If there is no therapeutic effectivenss observed after eight weeks, then the child may have their dose increased. In this case, the child will be followed for an additional eight weeks.

DRUG

Placebo

Patients in this study arm will receive capsules that appear identical to those of the two study drugs but will contain no active ingredient.

Trial Locations (1)

Unknown

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT00655174 - Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood? | Biotech Hunter | Biotech Hunter